| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |